Commonly Used Medications and Breast Cancer Recurrence
Contact: Denise Boudreau, Ph.D.
| Number of Enrolled Cancer Patients/Survivors: | 4,400 |
|---|---|
| Years of Diagnoses of Enrolled Cancer Patients/Survivors: | 1990-2008 |
| Approximate Years of Follow-up: | Median of 10 years (max. 18) |
| Cancer Sites Represented: | Breast |
| Biological Specimens Collected: | None |
| Treatment Outcome Measures: |
Physician/Medical Record Reported
|
| Co-morbidities at Study Entry: |
Diabetes Heart Disease Pulmonary Disease Other: Automated data on all co-morbidities during year prior to and during years following breast cancer diagnosis |
| Lifestyle Factors: |
Smoking Body Mass Index Weight Loss/Control |
| Treatment Data: |
Surgery Radiation Chemotherapy Hormonal Therapy Bone Marrow/Stem Cell Transplant |
| Treatment Data Assessed By: |
Administrative Claims Data Electronic Record Chart Abstraction Other: All medication dispensings per health plan records, self-reported side effects and reasons for discontinuing hormone therapy, tumor characteristics per SEER, second primaries, SEER link to other cancers, sociodemographics (race, education, geocoded data), screening, and surveillance history. |
| Is the study open to collaboration? | Yes |
